Golden logo
    Create a WorkspaceQuery ToolSaved QueriesData RequestsListsPipelinesExploreFollowed Topics
    Upgrade to ProPricingAPI AccessHelp & Support
Log in
Sign up
NEW: You can now make knowledge queries using our new natural language prompt. Try it out now!
⟶
Generation Bio

Generation Bio

Generation Bio is a biotechnology company that was founded in 2016

OverviewStructured DataIssuesContributorsActivity
Contents

Generation Bio is a company founded by Andrew Scharenberg, Mark D. Angelino, and Robert Kotin. The company has its headquarters located in Massachusetts, United States, and develops gene therapy treatments for patients suffering from rare and prevalent diseases.

Timeline

February 2018
Generation Bio raises a $100,000,000 series B round from Casdin Capital, Deerfield Management Company, Foresite Capital, Invus and Leerink Partners.
January 4, 2018
Generation Bio raises a $25,000,000 series A round from Atlas Venture.
2016
Generation Bio was founded by Andy Scharenberg and Mark Angelino.

Funding Rounds

Open in Query Tool

Products

Open in Query Tool

Acquisitions

Open in Query Tool

SBIR/STTR Awards

Open in Query Tool

Patents

Open in Query Tool

Further Resources

Title
Author
Link
Type
Date

References

generationbio.com
Is a
Organization
Organization
Company
Company

Company attributes

Industry
Gene therapy
Gene therapy
Immunotherapy
Immunotherapy
Diagnosis
Diagnosis
Therapeutics
Therapeutics
Consumer biotechnology
Consumer biotechnology
Biomedical engineering
Biomedical engineering
Technology
Technology
...
Location
Cambridge, Massachusetts
Cambridge, Massachusetts
B2X
B2B2C
B2B2C
CEO
‌
Geoffrey McDonough
Founder
‌
Mark Angelino
‌
Andy Scharenberg
Pitchbook URL
pitchbook.com/profiles...223773-49
Legal Name
Generation Bio Co.
Legal classification
Corporation
Corporation
Date Incorporated
2016
Number of Employees (Ranges)
100 – 249
Full Address
301 Binney Street Cambridge, MA 02142
CIK Number
1,733,294
Place of Incorporation
Delaware
Delaware
Investors
Invus
Invus
Foresite Capital
Foresite Capital
Atlas Venture
Atlas Venture
Deerfield Management Company
Deerfield Management Company
Casdin Capital
Casdin Capital
Leerink Partners
Leerink Partners
Fidelity Investments
Fidelity Investments
Fidelity
Fidelity
IRS Number
814,301,281
Email Address
info@generationbio.com
investors@generationbio.com
media@generationbio.com
partnering@generationbio.com
Phone Number
+16176557500
Total Funding Amount (USD)
336,842,608
Latest Funding Round Date
January 2020
Competitors
Akouos
Akouos
Stock Symbol
GBIO
Exchange
Nasdaq
Nasdaq
Glassdoor ID
2857849
Board of Directors
‌
Gustav A. Christensen
Jeff Jonas
Jeff Jonas
Jason Rhodes
Jason Rhodes
‌
Charles Rowland
‌
Dannielle Appelhans
‌
Catherine Stehman-Breen
CFO
‌
MATTHEW NORKUNAS
Latest Funding Type
Series B round
Series B round

Other attributes

Company Operating Status
Active
Country
United States
United States
Ticker Symbol
GBIO
Blog
generationbio.com/blog/
SIC Code
2,834
Golden logo
Company
HomePress & MediaBlogCareers
We're hiring
Products
OverviewKnowledge GraphQuery ToolData RequestsKnowledge StorageAPIPricingEnterpriseProtocol
Legal
Terms of ServiceEnterprise Terms of ServicePrivacy Policy
Help
Help centerAPI DocumentationContact Us
By using this site, you agree to our Terms of Service.